Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIEL SIMS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1669836532
CMS profile
4224987
Location
PROVO, UT

General Payments · PY2020–2023

$1,676.80

  • Reported across 39 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$531.58

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $403.60 15
Education $127.98 2

By paying entity

PY2023 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $99.95 1
PY2021 $351.60 3
PY2022 $693.67 18
PY2023 $531.58 17

Payment records · PY2023 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2023 202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $21.26 04/12/2023 Food and Beverage Undisputed 01/23/2026 1019879893 CMS
Astellas Pharma US Inc $57.99 02/06/2023 Education Undisputed 01/23/2026 1033898991 CMS
AstraZeneca Pharmaceuticals LP $13.46 01/12/2023 Food and Beverage Undisputed 01/23/2026 1011729289 CMS
AstraZeneca Pharmaceuticals LP $103.41 02/21/2023 Food and Beverage Undisputed 01/23/2026 1014214477 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.73 03/23/2023 Food and Beverage Undisputed 01/23/2026 1000503624 CMS
Daiichi Sankyo Inc. $15.10 01/19/2023 Food and Beverage Undisputed 01/23/2026 1006380341 CMS
Daiichi Sankyo Inc. $28.07 04/24/2023 Food and Beverage Undisputed 01/23/2026 1006345997 CMS
Genentech USA, Inc. $15.48 03/02/2023 Food and Beverage Undisputed 01/23/2026 1040336083 CMS
Janssen Biotech, Inc. $23.52 03/10/2023 Food and Beverage Undisputed 01/23/2026 988556453 CMS
Lilly USA, LLC $15.85 02/01/2023 Food and Beverage Undisputed 01/23/2026 1031363511 CMS
Merck Sharp & Dohme LLC $24.41 04/27/2023 Food and Beverage Undisputed 01/23/2026 1048611641 CMS
Novartis Pharmaceuticals Corporation $18.33 02/16/2023 Food and Beverage Undisputed 01/23/2026 993283635 CMS
Novartis Pharmaceuticals Corporation $20.51 04/14/2023 Food and Beverage Undisputed 01/23/2026 993283631 CMS
Novartis Pharmaceuticals Corporation $31.36 06/08/2023 Food and Beverage Undisputed 01/23/2026 993283639 CMS
Regeneron Healthcare Solutions, Inc. $27.61 06/22/2023 Food and Beverage Undisputed 01/23/2026 999446579 CMS
Seagen Inc. $69.99 06/08/2023 Education Undisputed 01/23/2026 995631477 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.50 01/27/2023 Food and Beverage Undisputed 01/23/2026 1055608037 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.